Swiss Firm Reveals Itself as Lek's Potential Bidder
Ljubljana, 26 August - Switzerland's Novartis is behind the potential takeover bid of Slovenian pharmaceutical Lek, revealed on Monday Lek chairman of the board Metod Dragonja. "Lek has a great interest in establishing a strategic partnership with long-term orientation, which would affirm Lek's market position on its traditional markets and especially facilitate the penetration to the Western European markets and the United States," stressed Dragonja. He expects that the takeover bid could be published by the end of the week.
The rest of this news item is available to subscribers.
The news item consists of 1.735 characters (without spaces) or 339 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.